Controlled Drugs and Substances Act

Legislative history and purpose

The Controlled Drugs and Substances Act was passed by the Parliament of Canada in 1996 as a comprehensive reform of the country's drug control laws. It specifically repealed the Narcotic Control Act and Parts III and IV of the Food and Drugs Act, which had created a fragmented and outdated system. The new law was designed to provide a more logical and scientifically grounded structure for regulating substances based on an assessment of their potential for harm, abuse, and therapeutic value. A core legal purpose of the CDSA is to fulfil Canada's obligations under three key United Nations drug control conventions. These are the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. The Act grants the Governor in Council, meaning the federal cabinet, the explicit authority to amend the Schedules of controlled substances by adding or deleting items through an order. This can be done when deemed necessary in the public interest, allowing the government to respond dynamically to emerging drug threats without requiring new primary legislation for each new substance.

The schedule system and listed substances

The Act organizes controlled substances into eight Schedules, numbered I through VIII, with each Schedule dictating the level of control and the severity of penalties for related offences. Schedule I contains substances considered to have the highest potential for harm and abuse, with little to no accepted medical use in Canada. This schedule is extensive and includes the opium poppy and all its preparations, derivatives, alkaloids and salts, such as opium, codeine, morphine, and thebaine. It also lists specific salts and derivatives like heroin (diacetylmorphine), oxycodone, hydromorphone, and fentanyl. The schedule also encompasses coca leaves and cocaine, phencyclidine (PCP) and ketamine, and amphetamines including methamphetamine and MDMA. Schedule II was originally designated for cannabis and its derivatives, but this schedule became largely obsolete with the passage of the separate Cannabis Act in 2018. Schedule III includes substances like amphetamines and their salts not listed in Schedule I, certain barbiturates, and flunitrazepam. Schedule IV includes various anabolic steroids and benzodiazepines other than flunitrazepam. Schedule V is for preparations containing limited quantities of narcotics like codeine. Schedules VI and VII list precursor chemicals used in the illicit production of controlled substances, and the Act also establishes two distinct Classes for precursors subject to specific controls.

Key amendments and the path to mandatory minimums

The CDSA has been amended several times since its inception, with significant changes focusing on sentencing. In November 2007, Justice Minister Rob Nicholson introduced Bill C-26, which proposed a number of mandatory minimum penalties for those who commit serious drug offences. This bill was later re-introduced as Bill C-15 in the second session of the 40th Parliament on February 27, 2009. Bill C-15 passed the House of Commons on June 9, 2009, and went to the Senate, which passed it with some amendments on December 14, 2009. However, when Parliament was prorogued on January 31, 2010, Bill C-15, along with all other unpassed legislation, died. The policy was ultimately enacted early in 2012 with the passage of the omnibus Safe Streets and Communities Act, which received Royal Assent in March of that year. The final legislation saw changes made to four areas of the CDSA, outlining mandatory minimum sentences of imprisonment for offences relating to the trafficking and production of various controlled substances. It is crucial to note that these mandatory minimum sentencing rules do not apply to the offence of simple possession, nor do they apply to trafficking in smaller amounts as defined by the regulations.

The 2026 Controlled Substances Regulations overhaul

A major regulatory modernization occurred with the introduction of the Controlled Substances Regulations, which came into force on October 1, 2026. Published in the Canada Gazette, Part II on December 17, 2025, following Health Canada's public consultations in 2024, these regulations consolidated several existing frameworks into a single, modernized set of rules. The new regulations replaced the Narcotic Control Regulations, the Benzodiazepines and Other Targeted Substances Regulations (BOTSR), and Parts G and J of the Food and Drug Regulations. They create a comprehensive framework under the CDSA to govern all activities with controlled substances, aiming to improve clarity, consistency, and harmonization across different substance categories. Authorities that were previously granted under temporary exemptions, most notably the subsection 56(1) exemption from the CDSA, are now permanently established under these new regulations. That temporary exemption, which introduced authorizations to support continuity of care during the COVID-19 pandemic starting in March 2020, remained in effect until September 30, 2026. The Controlled Substances Regulations list controlled substances in Schedules 1 to 4, replacing the older, fragmented listing system across multiple regulations.

Impact on healthcare professionals and pharmacy practice

The CDSA and its regulations have a direct and detailed impact on the practice of healthcare professionals, particularly pharmacists, pharmacy technicians, and physicians. The new Controlled Substances Regulations that took effect in October 2026 introduce several specific changes to practice authorities. The regulations explicitly state that pharmacy technicians and intern technicians can conduct defined activities with controlled substances. Furthermore, persons in charge of a hospital can permit an employee, including a pharmacy professional, to conduct activities with controlled substances as outlined in the rules. The regulations permanently authorize pharmacists to extend or renew prescriptions for controlled substances and to transfer such prescriptions between pharmacies, authorities that were previously temporary under the subsection 56(1) exemption. However, not all federal permissions apply uniformly across Canada because professional practice is governed by provincial legislation. Stricter provincial limits supersede broader federal permissions. For instance, therapeutic substitution of one controlled substance for another is not permitted in provinces like Ontario and British Columbia because it falls outside their provincially defined scopes of practice for pharmacists, even though the federal framework may allow it. Ontario pharmacists can, however, adapt prescriptions for controlled substances by changing the dose, dosage form, or regimen where permitted provincially.

Offences, penalties, and law enforcement application

The CDSA creates a comprehensive range of offences related to controlled substances and precursors. Key offences include possession of a substance listed in any Schedule, possession for the purpose of trafficking, trafficking itself, production, importation, and exportation. The severity of penalties upon conviction is directly tied to the Schedule of the substance involved and the nature and circumstances of the offence. For example, offences involving Schedule I or II substances generally carry the heaviest penalties, including the potential for life imprisonment for trafficking or production. The 2012 amendments introduced mandatory minimum sentences for certain serious offences, such as trafficking or production involving organized crime, or when the offence is committed near a school or other place frequented by youth. Simple possession, however, does not trigger a mandatory minimum sentence and is generally prosecuted as a less serious offence. The Act also includes provisions for the forfeiture of property used in or acquired through the commission of a drug offence. Law enforcement agencies across Canada, including the Royal Canadian Mounted Police, provincial, and municipal police forces, use the CDSA as the primary legal basis for investigations, charges, and seizures related to illicit drugs and precursor chemicals.

Administration, compliance, and recent procedural changes

The Controlled Drugs and Substances Act is jointly administered by Health Canada and the Department of Justice. Health Canada is responsible for the regulatory and public health aspects, including granting licenses for the legal production, distribution, and sale of controlled substances for medical, scientific, and industrial purposes. The Department of Justice is involved in the prosecution of offences under the Act. Compliance and enforcement are shared responsibilities. Health Canada's Controlled Substances Program oversees compliance within the legal supply chain, conducting inspections of licensed dealers, pharmacies, and hospitals. The program also provides guidance documents, such as the newly revised Controlled Substances Guidance for Community Pharmacists and Pharmacy Technicians (CS GD 022), released ahead of the 2026 regulations. The 2026 Controlled Substances Regulations streamlined several administrative requirements for regulated parties. For instance, pharmacy professionals are no longer required to notify Health Canada when transferring controlled substance inventory after a pharmacy permanently closes. Prior approval from Health Canada for the destruction of controlled substances is also no longer required under the new regulatory framework, simplifying operational procedures for hospitals and pharmacies.

Relationship with other laws and international context

The CDSA does not exist in isolation but interacts with other key pieces of Canadian legislation. Its most significant relationship is with the Cannabis Act, which came into effect on October 17, 2018. The Cannabis Act legalized the possession, sale, and production of cannabis for non-medical use, creating a separate regulatory regime and effectively removing cannabis from the purview of the CDSA for most purposes. Everyone with a criminal record for simple cannabis possession became eligible to apply for a pardon on that date. Internationally, the CDSA is the legislative vehicle through which Canada meets its obligations under the three main UN drug control treaties. This requires Canada to criminalize the non-medical use of substances listed in the treaties, to establish a system of licenses for legitimate activities, and to implement measures to prevent the diversion of precursors. The Act's provision allowing the Governor in Council to amend Schedules is critical for responding to new psychoactive substances identified by the international community. Furthermore, the consolidation of regulations in 2026 also involved the repeal of several federal items, including the Narcotic Control Regulations and specific class exemptions, with their authorities incorporated into the new Controlled Substances Regulations framework.

Questions about Controlled Drugs and Substances Act

What is the Controlled Drugs and Substances Act?

The Controlled Drugs and Substances Act is Canada's main federal law that controls the possession, production, distribution, and sale of drugs and other substances deemed to pose a risk of harm or abuse. Passed in 1996, it establishes a system of eight Schedules that classify substances like opioids, stimulants, and benzodiazepines based on their potential for harm. The Act outlines the criminal offences and penalties associated with illegal activities involving these substances. It also provides the framework for the legal, regulated use of controlled substances for medical and scientific purposes under license from Health Canada.

What changed with the new Controlled Substances Regulations in 2026?

On October 1, 2026, the new Controlled Substances Regulations came into force, consolidating several older regulations into a single, modernized framework. They replaced the Narcotic Control Regulations, the Benzodiazepines and Other Targeted Substances Regulations, and Parts G and J of the Food and Drug Regulations. The new regulations permanently established authorities that were previously under temporary exemptions, such as a pharmacist's ability to extend or transfer prescriptions for controlled substances. They also simplified administrative tasks, like removing the requirement to notify Health Canada about inventory transfers when a pharmacy closes permanently and eliminating the need for prior approval for the destruction of controlled substances.

Does the CDSA apply to cannabis?

Since October 17, 2018, cannabis has been largely removed from the Controlled Drugs and Substances Act. On that date, the federal Cannabis Act came into effect, legalizing and creating a strict regulatory framework for the production, distribution, sale, and possession of cannabis for non medical use. The CDSA no longer applies to cannabis activities that are permitted under the Cannabis Act. However, illicit activities involving cannabis outside that legal framework could still be prosecuted under other laws. The Cannabis Act also made individuals with past convictions for simple cannabis possession eligible to apply for a pardon as of the Act's coming into force.

What are mandatory minimum sentences under the CDSA?

Mandatory minimum sentences are prison terms that a judge must impose upon conviction for certain serious drug offences under the CDSA. They were introduced through amendments in the Safe Streets and Communities Act of 2012. These minimum sentences apply to offences like trafficking, production, and possession for the purpose of trafficking involving substances in Schedules I or II, particularly when aggravating factors are present. Aggravating factors include involvement of organized crime, use of violence or weapons, or committing the offence near a school. It is important to note that the offence of simple possession does not carry a mandatory minimum sentence, nor does trafficking in smaller amounts as defined by regulation.

Can a pharmacist substitute a different controlled substance for the one prescribed?

The ability of a pharmacist to therapeutically substitute one controlled substance for another is not universally permitted across Canada. While the federal Controlled Substances Regulations provide a framework, professional practice is governed by provincial legislation. Provinces like Ontario and British Columbia have stricter rules that do not include therapeutic substitution of controlled substances within a pharmacist's scope of practice. Therefore, even if the federal regulations allow for certain flexibilities, pharmacists in those provinces cannot make such substitutions unless specifically authorized by provincial law. Pharmacists can, however, adapt prescriptions in other ways, such as changing the dose or dosage form, where permitted by provincial bylaws.

How are new drugs added to the CDSA Schedules?

The Controlled Drugs and Substances Act allows the Governor in Council, which is the federal cabinet, to amend the Schedules by adding or deleting substances through an order. This is done when the government deems the amendment to be necessary in the public interest. The process typically involves a scientific and risk assessment by Health Canada to evaluate the substance's potential for harm, abuse, liability for diversion, and therapeutic value. The government also considers Canada's international treaty obligations under the UN drug conventions. Once a substance is added to a Schedule via this regulatory process, the controls and penalties associated with that Schedule immediately apply to it. This mechanism allows Canada to respond rapidly to emerging drug threats, such as new synthetic opioids like U-47700 or stimulants like MDPV.

Sources: Wikipedia and current public reporting, checked by the Nosy Mag desk. Last updated 2026-10-22.